News articles about Mazor Robotics (NASDAQ:MZOR) have trended somewhat positive on Monday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Mazor Robotics earned a news impact score of 0.12 on Accern’s scale. Accern also assigned news coverage about the medical instruments supplier an impact score of 45.1610945193301 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news articles that may have impacted Accern Sentiment’s rankings:
- 3 Top Robotic-Surgery Stocks to Consider Buying Now (finance.yahoo.com)
- Mazor Robotics Ltd – (MZOR) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com)
- Mazor Robotics (MZOR) Stock Rating Lowered by BidaskClub (americanbankingnews.com)
- Investor’s Alert: Mazor Robotics Ltd. (NASDAQ:MZOR), Cloud Peak Energy Inc. (NYSE:CLD) – The Oracle Examiner (oracleexaminer.com)
- Mazor Robotics Ltd. (MZOR) stock recent close stands at $61.08 … – Nasdaq Fortune (press release) (nasdaqfortune.com)
Mazor Robotics (NASDAQ MZOR) opened at $59.50 on Monday. The company has a market cap of $1,518.56, a P/E ratio of -116.67 and a beta of 1.18. Mazor Robotics has a 1 year low of $25.24 and a 1 year high of $76.56.
MZOR has been the subject of several analyst reports. BidaskClub lowered shares of Mazor Robotics from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Zacks Investment Research raised shares of Mazor Robotics from a “hold” rating to a “buy” rating and set a $61.00 price target for the company in a research report on Wednesday, December 13th. Barclays reissued a “sell” rating and set a $36.00 price target on shares of Mazor Robotics in a research report on Tuesday, January 9th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Mazor Robotics in a research report on Wednesday, February 14th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Mazor Robotics currently has an average rating of “Hold” and a consensus price target of $49.21.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include Renaissance Guidance System, which can improve the execution and outcomes in a wide variety of procedures, including percutaneous degenerative repair, pedicle screw fixation for complex spinal deformity, and vertebral augmentation; Mazor X, the Surgical Assurance Platform for Spine Surgery.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.